Cargando…
Interactions between Medical Residents and Drug Companies: A National Survey after the Mediator® Affair
BACKGROUND: The present study aimed to describe exposure and attitudes of French medical residents towards pharmaceutical industry. The study was performed shortly after the Mediator affair which revealed several serious conflicts of interest inside the French health system. METHODS AND FINDINGS: A...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184806/ https://www.ncbi.nlm.nih.gov/pubmed/25279555 http://dx.doi.org/10.1371/journal.pone.0104828 |
_version_ | 1782337918328635392 |
---|---|
author | Montastruc, François Moulis, Guillaume Palmaro, Aurore Gardette, Virginie Durrieu, Geneviève Montastruc, Jean-Louis |
author_facet | Montastruc, François Moulis, Guillaume Palmaro, Aurore Gardette, Virginie Durrieu, Geneviève Montastruc, Jean-Louis |
author_sort | Montastruc, François |
collection | PubMed |
description | BACKGROUND: The present study aimed to describe exposure and attitudes of French medical residents towards pharmaceutical industry. The study was performed shortly after the Mediator affair which revealed several serious conflicts of interest inside the French health system. METHODS AND FINDINGS: A cross-sectional study was implemented among residents from 6 French medical faculties. Independent education in pharmacology, attitudes towards the practices of pharmaceutical sales representatives, opinions concerning the pharmaceutical industry, quality of information provided by the pharmaceutical industry, and opinions about pharmaceutical company sponsorship were investigated through a web-based questionnaire. We also assessed potential changes in resident attitudes following the Mediator affair. The mean value of exposure to drug companies was 1.9 times per month. Global opinions towards drug company information were negative for 42.7% of the residents and positive for only 8.2%. Surprisingly, 81.6% of residents claimed that they had not changed their practices regarding drug information since the Mediator affair. Multivariate analyses found that residents in anesthesiology were less likely to be exposed than others (OR = 0.17 CI95% [0.05–0.61]), exposure was significantly higher at the beginning of residence (p<0.001) and residents who had a more positive opinion were more frequently exposed to drug companies (OR = 2.12 CI95% [1.07–4.22]). CONCLUSIONS: Resident exposure to drug companies is around 1 contact every 2 weeks. Global opinion towards drug information provided by pharmaceutical companies was negative for around 1 out of 2 residents. In contrast, residents tend to consider the influences of the Mediator affair on their practice as relatively low. This survey enabled us to identify profiles of residents who are obviously less exposed to pharmaceutical industry. Current regulatory provisions are not sufficient, indicating that further efforts are necessary to develop a culture of disclosure of conflict of interest and of transparency in residents. |
format | Online Article Text |
id | pubmed-4184806 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-41848062014-10-07 Interactions between Medical Residents and Drug Companies: A National Survey after the Mediator® Affair Montastruc, François Moulis, Guillaume Palmaro, Aurore Gardette, Virginie Durrieu, Geneviève Montastruc, Jean-Louis PLoS One Research Article BACKGROUND: The present study aimed to describe exposure and attitudes of French medical residents towards pharmaceutical industry. The study was performed shortly after the Mediator affair which revealed several serious conflicts of interest inside the French health system. METHODS AND FINDINGS: A cross-sectional study was implemented among residents from 6 French medical faculties. Independent education in pharmacology, attitudes towards the practices of pharmaceutical sales representatives, opinions concerning the pharmaceutical industry, quality of information provided by the pharmaceutical industry, and opinions about pharmaceutical company sponsorship were investigated through a web-based questionnaire. We also assessed potential changes in resident attitudes following the Mediator affair. The mean value of exposure to drug companies was 1.9 times per month. Global opinions towards drug company information were negative for 42.7% of the residents and positive for only 8.2%. Surprisingly, 81.6% of residents claimed that they had not changed their practices regarding drug information since the Mediator affair. Multivariate analyses found that residents in anesthesiology were less likely to be exposed than others (OR = 0.17 CI95% [0.05–0.61]), exposure was significantly higher at the beginning of residence (p<0.001) and residents who had a more positive opinion were more frequently exposed to drug companies (OR = 2.12 CI95% [1.07–4.22]). CONCLUSIONS: Resident exposure to drug companies is around 1 contact every 2 weeks. Global opinion towards drug information provided by pharmaceutical companies was negative for around 1 out of 2 residents. In contrast, residents tend to consider the influences of the Mediator affair on their practice as relatively low. This survey enabled us to identify profiles of residents who are obviously less exposed to pharmaceutical industry. Current regulatory provisions are not sufficient, indicating that further efforts are necessary to develop a culture of disclosure of conflict of interest and of transparency in residents. Public Library of Science 2014-10-03 /pmc/articles/PMC4184806/ /pubmed/25279555 http://dx.doi.org/10.1371/journal.pone.0104828 Text en © 2014 Montastruc et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Montastruc, François Moulis, Guillaume Palmaro, Aurore Gardette, Virginie Durrieu, Geneviève Montastruc, Jean-Louis Interactions between Medical Residents and Drug Companies: A National Survey after the Mediator® Affair |
title | Interactions between Medical Residents and Drug Companies: A National Survey after the Mediator® Affair |
title_full | Interactions between Medical Residents and Drug Companies: A National Survey after the Mediator® Affair |
title_fullStr | Interactions between Medical Residents and Drug Companies: A National Survey after the Mediator® Affair |
title_full_unstemmed | Interactions between Medical Residents and Drug Companies: A National Survey after the Mediator® Affair |
title_short | Interactions between Medical Residents and Drug Companies: A National Survey after the Mediator® Affair |
title_sort | interactions between medical residents and drug companies: a national survey after the mediator® affair |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184806/ https://www.ncbi.nlm.nih.gov/pubmed/25279555 http://dx.doi.org/10.1371/journal.pone.0104828 |
work_keys_str_mv | AT montastrucfrancois interactionsbetweenmedicalresidentsanddrugcompaniesanationalsurveyafterthemediatoraffair AT moulisguillaume interactionsbetweenmedicalresidentsanddrugcompaniesanationalsurveyafterthemediatoraffair AT palmaroaurore interactionsbetweenmedicalresidentsanddrugcompaniesanationalsurveyafterthemediatoraffair AT gardettevirginie interactionsbetweenmedicalresidentsanddrugcompaniesanationalsurveyafterthemediatoraffair AT durrieugenevieve interactionsbetweenmedicalresidentsanddrugcompaniesanationalsurveyafterthemediatoraffair AT montastrucjeanlouis interactionsbetweenmedicalresidentsanddrugcompaniesanationalsurveyafterthemediatoraffair |